GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » YoY EPS Growth

Talphera (FRA:R5XA) YoY EPS Growth : 79.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Talphera YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Talphera's YoY EPS Growth for the quarter that ended in Mar. 2024 was 79.00%.

Talphera's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.15.

Talphera YoY EPS Growth Historical Data

The historical data trend for Talphera's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera YoY EPS Growth Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.31 35.93 32.88 204.13 -121.91

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.25 -104.55 92.10 79.56 79.00

Talphera YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Talphera's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-1.183-5.4)/ | 5.4 |
=-121.91 %

Talphera's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-0.147--0.7)/ | -0.7 |
=79.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Talphera's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Talphera (FRA:R5XA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » YoY EPS Growth
Comparable Companies
UNRV RLBD SBFM GHSI SHPH BUDZ FLGC CVSI DMK BFRI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
TLPH:USA
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Website
https://www.acelrx.com
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (FRA:R5XA) Headlines

No Headlines